Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 12:05 AM ET

Pharmaceuticals

Company Overview of Eurofarma Laboratórios S.A.

Company Overview

Eurofarma Laboratórios S.A. produces and markets medical prescription, veterinary, and over-the-counter drugs. It also offers medicines for hospital use, which include antibiotics, anesthetics, antifungals, antivirals, uterine stimulants, exchange resins, anti-ulcer, anti-inflammatory, and anticoagulant drugs; and serums in bags and jars. In addition, the company provides antiparasitic, vitamins, and tonics for the prevention and treatment of diseases primarily in cattle; and oncology drugs. Further, it manufactures medicines of various therapeutic classes and in various dosage forms, including cosmetics and hygiene products to other laboratories. Further, the company offers ampoules and via...

Av. Vereador José Diniz, nº 3465

Campo Belo

São Paulo, SP 04603-003

Brazil

Founded in 1972

Phone:

55 11 5090 8600

Fax:

55 11 5090 8742

Key Executives for Eurofarma Laboratórios S.A.

Eurofarma Laboratórios S.A. does not have any Key Executives recorded.

Eurofarma Laboratórios S.A. Key Developments

Melinta Therapeutics, Inc. Partners with Eurofarma Laboratorios S.A

Melinta Therapeutics, Inc. and Eurofarma Laboratorios S.A. have entered into commercialization and distribution agreements for delafloxacin, an investigational fluoroquinolone. Under the terms of the agreements, Eurofarma will be responsible for obtaining regulatory approval in Brazil and will then have the right to market, sell and distribute delafloxacin in that country for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Melinta will receive a combined upfront cash and equity payment of $15 million, as well as milestones and royalties on future sales of delafloxacin.

Eurofarma Seeks Acquisitions In Mexico And Latin America

Eurofarma Laboratorios Ltda. is looking for acquisitions opportunities. Maria Del Pilar Muñoz Director of Eurofarma said that Eurofarma aims to have established operations in Mexico and the second largest market in Latin America by 2015. It is planning to acquire 90% share of the Latin American pharmaceutical market, in which it has 70% share.

Recent Private Companies Transactions

Type
Date
Target
Private Placement
January 8, 2015
Melinta Therapeutics, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Eurofarma Laboratórios S.A., please visit www.eurofarma.com.br. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.